Editorial
Abstract
Authors
Elizabeth M. McNally
Abstract
“On behalf of all authors of the submission, I warrant that the work is original and scientifically accurate ...” If you’ve submitted a manuscript to the Journal of Clinical Investigation or JCI Insight, this phrase should sound familiar. This statement is the very first thing that we ask authors to verify for every new submission. While this may seem like a simple formality or just another screen to click through, certifying the accuracy of information presented to the journal is essential to the publishing process and scientific integrity. Data accuracy forms the foundation of the scientific enterprise, and without it, the enterprise risks crumbling.
Authors
Sarah Jackson, Corinne L. Williams, Kathleen L. Collins, Elizabeth M. McNally
Abstract
As the curtain draws on the 5-year term of the JCI editorial board at Johns Hopkins, I am filled with gratitude and would like to extend a warm ayekoo (Ghanaian salutation meaning “well done”) to our editors, staff, reviewers, and scientists for supporting the Journal. I am delighted to welcome the next JCI Editor in Chief, Elizabeth McNally — the first woman to lead the JCI since it was founded almost a century ago — and her team from Northwestern University.
Authors
Rexford S. Ahima
Abstract
In this editorial, we describe the experience of the JCI editors during the COVID-19 pandemic. Our goal is to share how we operated during the pandemic, recount how the JCI contributed to the response, highlight some of the major papers we published on SARS-CoV-2 and COVID-19, and impart our insights in the hope that these are helpful to journal editors that may need to deal with similar types of crises in the future.
Authors
Arturo Casadevall, Sarah Jackson, Gregg L. Semenza, Gordon F. Tomaselli, Rexford S. Ahima
Abstract
The editors of JCI and JCI Insight are revisiting our editorial processes in light of the strain that the COVID-19 pandemic places on the worldwide scientific community. Here, we discuss adjustments to our decision framework in light of restrictions placed on laboratory working conditions for many of our authors.
Authors
Rexford S. Ahima, Sarah Jackson, Arturo Casadevall, Gregg L. Semenza, Gordon Tomaselli, Kathleen L. Collins, Andrew P. Lieberman, Donna M. Martin, Pavan Reddy
Abstract
Reflecting an increasing emphasis on collaborative science, the number of authors on published articles has markedly risen with time. With this trend, we see an increase in papers designating 2 or more co–first authors. To improve transparency in how such designations are made and reduce bias in the assignment of order, the JCI is now requiring an explanation for how the first-author position is determined when shared among contributing authors.
Authors
Arturo Casadevall, Gregg L. Semenza, Sarah Jackson, Gordon Tomaselli, Rexford S. Ahima
Abstract
Recent reports suggest that there has been an increase in the number of retractions and corrections of published articles due to post-publication detection of problematic data. Moreover, fraudulent data and sloppy science have long-term effects on the scientific literature and subsequent projects based on false and unreproducible claims. At the JCI, we have introduced several data screening checks for manuscripts prior to acceptance in an attempt to reduce the number of post-publication corrections and retractions, with the ultimate goal of increasing confidence in the papers we publish.
Authors
Corinne L. Williams, Arturo Casadevall, Sarah Jackson
Abstract
The JCI has made all of its research freely available to readers since 1996. As open access mandates from funders, such as Plan S, gain momentum, it’s worth revisiting how the JCI has created a durable publication model for free access to research and the benefits that society journals provide to the research community.
Authors
Sarah Jackson
No posts were found with this tag.
Copyright © 2024 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)